Poly(ADP-Ribose) Polymerase in Cervical Cancer Pathogenesis: Mechanism and Potential Role for PARP Inhibitors

Ioannis C Kotsopoulos1, Ali Kucukmetin, Asima Mukhopadhyay

  • 1*Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead; and †Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.

Insights

Poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors show promise for treating advanced cervical cancer, offering a targeted approach beyond palliative chemotherapy. Research is ongoing to evaluate their efficacy and role in cervical carcinomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Limited treatment options exist for recurrent advanced cervical cancer, primarily palliative chemotherapy with low efficacy.
  • There is a critical need for novel targeted therapeutic agents.
  • Poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors (PARPi) are a promising class of agents for DNA repair-deficient cancers.

Purpose of the Study:

  • To review the role of PARP in cervical intraepithelial neoplasia and invasive cervical cancer.
  • To explore PARP expression, mechanism of action, and the impact of polymorphisms in cervical cancer pathogenesis.
  • To evaluate the therapeutic potential of PARP inhibitors in cervical cancer.

Main Methods:

  • Comprehensive literature review of existing studies on PARP and PARPi in cervical cancer.
  • Analysis of PARP expression, function, and genetic polymorphisms.
  • Evaluation of data from ongoing clinical trials of PARPi in cervical cancer.

Main Results:

  • PARP plays a significant role in cervical cancer development and progression.
  • PARPi demonstrate therapeutic potential, with several clinical trials underway.
  • Understanding PARP's role may lead to new treatment strategies.

Conclusions:

  • PARP inhibitors represent a promising targeted therapy for advanced and recurrent cervical cancer.
  • Further research and clinical trials are essential to establish the efficacy of PARPi.
  • A new unifying theory on the role of PARPs in cervical carcinoma development is proposed.

Related Concept Videos

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K